Exploring the Link Between Bevacizumab and Gastrointestinal Perforations Using the FDA Adverse Event Reporting System Database

被引：0
|
作者：
Wichelmann, Thomas A. [1 ]
Abdulmujeeb, Sufyan [1 ]
Ehrenpreis, Eli D. [1 ]
机构：
[1] Advocate Lutheran Gen Hosp, Park Ridge, IL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2020年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S0236
引用
收藏
页码：S114 / S115
页数：3
相关论文
共 50 条
  • [21] An Experimental Investigation of Masking in the US FDA Adverse Event Reporting System Database
    Wang, Hsin-wei
    Hochberg, Alan M.
    Pearson, Ronald K.
    Hauben, Manfred
    DRUG SAFETY, 2010, 33 (12) : 1117 - 1133
  • [22] An Experimental Investigation of Masking in the US FDA Adverse Event Reporting System Database
    Hsin-wei Wang
    Alan M. Hochberg
    Ronald K. Pearson
    Manfred Hauben
    Drug Safety, 2010, 33 : 1117 - 1133
  • [23] Differences in Anaphylaxis Reporting Among Cephalosporins: Analysis of the FDA Adverse Event Reporting System Database
    Shah, Divya
    Stone, Cosby
    Rukasin, Christine
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB77 - AB77
  • [24] Adverse event profile differences between rituximab and ocrelizumab: Findings from the FDA Adverse Event Reporting Database
    Caldito, Natalia Gonzalez
    Shirani, Afsaneh
    Salter, Amber
    Stuve, Olaf
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (07) : 1066 - 1076
  • [25] Adverse event profile differences between rituximab and ocrelizumab: findings from the fda adverse event reporting database
    Caldito, N. Gonzalez
    Shirani, A.
    Salter, A.
    Stuve, O.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 257 - 257
  • [26] Novel Adverse Events of Bevacizumab in the US FDA Adverse Event Reporting System DatabaseA Disproportionality Analysis
    Behrooz K. Shamloo
    Pankdeep Chhabra
    Andrew N. Freedman
    Arnold Potosky
    Jennifer Malin
    Sheila Weiss Smith
    Drug Safety, 2012, 35 : 507 - 518
  • [27] Novel adverse events of blonanserin: a disproportionality analysis in the FDA Adverse Event Reporting System database
    Subeesh, Viswam
    Singh, Hemendra
    Maheswari, Eswaran
    Beulah, Thomas
    MINERVA PSICHIATRICA, 2018, 59 (02): : 105 - 110
  • [28] Adverse Effects of Clopidogrel: a Cross Sectional Study of the FDA Adverse Event Reporting System Database
    Al-Saikhan, Fahad
    Ahmad, Nehad
    Abd-Elaziz, Mohamed
    Iqbal, Muhammad Shahid
    LATIN AMERICAN JOURNAL OF PHARMACY, 2022, 41 (07): : 1388 - 1391
  • [29] Exploring the safety profile of tremelimumab: an analysis of the FDA adverse event reporting system
    Yibei Zhao
    Huiming Jiang
    Lifen Xue
    Mi Zhou
    Xiaobing Zhao
    Fei Liu
    SongJiang Jiang
    Jing Huang
    Long Meng
    International Journal of Clinical Pharmacy, 2024, 46 : 480 - 487
  • [30] Exploring the safety profile of tremelimumab: an analysis of the FDA adverse event reporting system
    Zhao, Yibei
    Jiang, Huiming
    Xue, Lifen
    Zhou, Mi
    Zhao, Xiaobing
    Liu, Fei
    Jiang, Songjiang
    Huang, Jing
    Meng, Long
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2024, 46 (02) : 480 - 487
12345